These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 101702)

  • 1. L-form of Pseudomonas aeruginosa. 2. Antibiotic sensitivity of L-forms and their parent forms.
    Yamamoto A; Homma JY
    Jpn J Exp Med; 1978 Aug; 48(4):355-62. PubMed ID: 101702
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the combined action of antibiotics on Pseudomonas aeruginosa strains.
    Muszyński Z; Kedzia W
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):743-51. PubMed ID: 4358926
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.
    Maciá MD; Mena A; Borrell N; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4531-2. PubMed ID: 17893154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin.
    Goldstein FW; Ly A; Kitzis MD
    J Antimicrob Chemother; 2007 May; 59(5):1039-40. PubMed ID: 17437963
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y; Wang R; Liang BB; An MM
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on new antibiotic lividomycins. V. In vitro and in vivo antimicrobial activity of lividomycin A.
    Kobayashi F; Nagoya T; Yoshimura Y; Kaneko K; Ogata SI
    J Antibiot (Tokyo); 1972 Feb; 25(2):128-36. PubMed ID: 4624613
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of blaGES-5 in clinical colistin-only-sensitive (COS) Pseudomonas aeruginosa strain in Brazil.
    da Fonseca EL; Vieira VV; Cipriano R; Vicente AC
    J Antimicrob Chemother; 2007 Mar; 59(3):576-7. PubMed ID: 17284538
    [No Abstract]   [Full Text] [Related]  

  • 9. Colistin: an antimicrobial for the 21st century?
    Stein A; Raoult D
    Clin Infect Dis; 2002 Oct; 35(7):901-2. PubMed ID: 12228836
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell wall characteristics of Pseudomonas aeruginosa and its carbenicillin-induced L-form.
    White CJ; Horsman MR; Rowe PS; Howells KF
    Acta Biol Acad Sci Hung; 1978; 29(1):67-74. PubMed ID: 112813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of "Pseudomonas aeruginosa" to combinations of antibiotics.
    Klastersky J; Beumer J; Daneau D
    Pathol Biol (Paris); 1972 Sep; 20(15):643-7. PubMed ID: 4342650
    [No Abstract]   [Full Text] [Related]  

  • 13. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.
    Drenkard E; Ausubel FM
    Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three standardized disc susceptibility testing methods for colistin.
    Tan TY; Ng LS
    J Antimicrob Chemother; 2006 Oct; 58(4):864-7. PubMed ID: 16905528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
    Cox HU; Luther DG
    Am J Vet Res; 1980 Jun; 41(6):906-9. PubMed ID: 6776851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of antibiotic sensitivity of Pseudomonas aeruginosa in vitro].
    Romano A; Levré E; Lauro P
    Riv Ital Ig; 1968; 28(5):598-605. PubMed ID: 4988221
    [No Abstract]   [Full Text] [Related]  

  • 20. [The "in vitro" sensitivity of pseudomonas aeruginosa to antibiotic and chemotherapeutic agents (author's transl)].
    Paredes L; Valenzuela E; Caorsi B; Castillo M
    Rev Med Chil; 1976 Sep; 104(9):615-9. PubMed ID: 828758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.